Latest News & Features
Americas
Watson Laboratories has secured a win at the US Court of Appeals for the Federal Circuit, after the court said Watson did prove that Bayer’s patent claims were obvious. 2 November 2017
Big Pharma
The English Court of Appeal has ruled that patent claims protecting blockbuster drug Cialis (tadalafil) are invalid as obvious, handing victory to Actavis, Teva and Mylan. 1 November 2017
Big Pharma
Swiss pharmaceutical company Novartis has bolstered its oncology portfolio with the acquisition of Advanced Accelerator Applications. 1 November 2017
Americas
The Patent Trial and Appeal Board has agreed to rehear an inter partes review (IPR) filed by Hospira, a company now owned by Pfizer. 31 October 2017
Americas
Bayer Healthcare and Mylan have settled their differences over a generic version of Bayer’s liver cancer drug Nexavar (sorafenib tosylate). 30 October 2017
Americas
The US Department of Justice has dropped its case against a dual citizen of Canada and China who was charged in connection with attempting to steal trade secrets. 30 October 2017
Big Pharma
The English High Court has invalidated two patent claims protecting Copaxone (glatiramer acetate), a billion-dollar drug marketed by Teva. 27 October 2017
Americas
Merck Sharp & Dohme (MSD) has suffered a loss at the US Court of Appeals for the Federal Circuit, after the court affirmed an earlier finding of obviousness. 27 October 2017
Americas
Non-profit group the Initiative for Medicines, Access & Knowledge (I-MAK) has accused Gilead of obtaining “unmerited patents” for its hepatitis C medicine sofosbuvir. 26 October 2017
Americas
The Broad Institute of Harvard and MIT has adopted three major arguments in its response to the University of California, Berkeley’s appeal against a patent finding on the CRISPR technology. 26 October 2017